Literature DB >> 7390164

Effect of treatment with phenformin, diphenylhydantoin or L-dopa on life span and tumour incidence in C3H/Sn mice.

V M Dilman, V N Anisimov.   

Abstract

The chronic treatment of female C3H/Sn mice with phenformin (2 mg/day) and diphenylhydantoin (2 mg/day) prolonged mean life span by 23 and 25%, respectively, and decreased spontaneous tumour incidence by 4.0 and 2.3 times, respectively. The chronic treatment of mice with L-dopa (2 mg/day) did not change these parameters and decreased the multiplicity of mammary tumours. The mechanisms of the drug action on mouse life span and tumour incidence are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7390164     DOI: 10.1159/000212423

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  40 in total

Review 1.  Calorie restriction: what recent results suggest for the future of ageing research.

Authors:  Daniel L Smith; Tim R Nagy; David B Allison
Journal:  Eur J Clin Invest       Date:  2010-05       Impact factor: 4.686

Review 2.  Aging and TOR: interwoven in the fabric of life.

Authors:  Zelton Dave Sharp
Journal:  Cell Mol Life Sci       Date:  2010-10-21       Impact factor: 9.261

3.  Enhanced insulin-hypoglycemic activity in rats consuming a specific glycoprotein extracted from maitake mushroom.

Authors:  Harry G Preuss; Bobby Echard; Debasis Bagchi; Nicholas V Perricone; Cun Zhuang
Journal:  Mol Cell Biochem       Date:  2007-08-01       Impact factor: 3.396

Review 4.  Hormonal regulation of longevity in mammals.

Authors:  Holly M Brown-Borg
Journal:  Ageing Res Rev       Date:  2007-02-20       Impact factor: 10.895

5.  Molecular basis of ageing.

Authors:  Matt Kaeberlein
Journal:  EMBO Rep       Date:  2007-09-07       Impact factor: 8.807

Review 6.  The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.

Authors:  Vladimir N Anisimov; Andrzej Bartke
Journal:  Crit Rev Oncol Hematol       Date:  2013-02-21       Impact factor: 6.312

Review 7.  TOR signaling never gets old: aging, longevity and TORC1 activity.

Authors:  Daniel S Evans; Pankaj Kapahi; Wen-Chi Hsueh; Lutz Kockel
Journal:  Ageing Res Rev       Date:  2010-04-10       Impact factor: 10.895

8.  Sex differences in aging, life span and spontaneous tumorigenesis in 129/Sv mice neonatally exposed to metformin.

Authors:  Vladimir N Anisimov; Irina G Popovich; Mark A Zabezhinski; Peter A Egormin; Maria N Yurova; Anna V Semenchenko; Margarita L Tyndyk; Andrey V Panchenko; Alexandr P Trashkov; Andrey G Vasiliev; Nikolai V Khaitsev
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

9.  Trade-off between cancer and aging: what role do other diseases play? Evidence from experimental and human population studies.

Authors:  Anatoli I Yashin; Svetlana V Ukraintseva; Igor V Akushevich; Konstantin G Arbeev; Alexander Kulminski; Lucy Akushevich
Journal:  Mech Ageing Dev       Date:  2008-03-25       Impact factor: 5.432

Review 10.  Validation of anti-aging drugs by treating age-related diseases.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2009-03-28       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.